Satellos Bioscience's market cap is currently ―. The company's EPS TTM is $-0.134; its P/E ratio is -2.89; Satellos Bioscience is scheduled to report earnings on May 28, 2024, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	C$ -3.52K	C$ -4.00M	C$ -1.66M	C$ -5.07M	C$ -1.90M
EBITDA	C$ -5.83K	C$ -4.00M	C$ -1.66M	C$ -4.84M	C$ -2.00M
Net Income Common Stockholders	C$ -3.57K	C$ -4.11M	C$ -1.67M	C$ -5.07M	C$ -1.90M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 44.26K	C$ 48.73M	C$ 2.98M	C$ 1.92M	C$ 3.13M
Total Assets	C$ 48.68K	C$ 53.07M	C$ 7.05M	C$ 6.20M	C$ 10.22M
Total Debt	C$ 0.00	C$ 2.08M	C$ 2.03M	C$ 0.00	C$ 0.00
Net Debt	C$ -44.26K	C$ -46.65M	C$ -957.26K	C$ -1.92M	C$ -3.13M
Total Liabilities	C$ 2.32K	C$ 3.88M	C$ 4.92M	C$ 2.83M	C$ 2.02M
Stockholders Equity	C$ 46.36K	C$ 49.19M	C$ 2.13M	C$ 3.37M	C$ 8.21M
Cash Flow	-
Free Cash Flow	-	C$ -3.89M	C$ -1.18M	C$ -4.14M	C$ -1.58M
Operating Cash Flow	C$ 5.06M	C$ -3.88M	C$ -1.18M	C$ -4.13M	C$ -1.58M
Investing Cash Flow	C$ 6.85K	C$ -6.87K	-	C$ -1.25K	C$ -2.22K
Financing Cash Flow	C$ -53.00M	C$ 50.81M	C$ 2.24M	C$ -7.23K	C$ 2.78M

Currency in CAD

Satellos Bioscience Earnings and Revenue History

Income Statement >

Satellos Bioscience Debt to Assets

Balance Sheet >

Satellos Bioscience Cash Flow

Cash Flow >

Satellos Bioscience Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing